1. Ackenheil, M., Beckmann, H., Greil, W., Hoffmann, G., Markianos, E., Raese, T.: Antipsychotic efficacy of clozapine in correlation to changes in catecholamine metabolism in man. In: The phenothiazines and structurally related drugs. C. Forrest, T. C. Carr, and E. Usdin, eds., pp. 647?657. New York: Raven Press 1974
2. Andén, N. E., Corrodi, H., Fuxe, K., Hökfelt, T.: Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide. Br. J. Pharmacol. 34, 1?7 (1968)
3. Angst, J., Battegay, R., Bente, D., Berner, P., Broeren, W., Heinemann, H., Heinrich, H., Engelmeier, M. P., Cornu, F., Dick, P., Hippius, H., Poeldinger, W., Schmidlein, P., Schmitt, W., Weiss, P.: Dokumentationssystem der Arbeitsgemeinschaft für Methodik und Dokumentationssystem in der Psychiatrie. (AMP) Arzneim. Forsch. (Drug. Res.) 19, 399?405 (1969)
4. Ashcroft, G. W., Crawford, T. B. B., Eccleston, D., Sharman, D. F., MacDougall, E. J., Stanton, J. B., Binns, J. K.: 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet 1966 II, 1049?1052
5. Bennett, J. L., Aghajanian, G. K.: D-LSD binding to brain homogenates: possible relationship to serotonin receptors. Life Sci. 15, 1935?1944 (1974)